Compare, Analyse Sterling Biotech with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ACTAVIS (US) - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   ACTAVIS
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ACTAVIS
Dec-18
STERLING BIOTECH/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1113,729-   
Low Rs39,209-   
Sales per share (Unadj.) Rs26.83,367.7-  
Earnings per share (Unadj.) Rs-15.0-1,084.7-  
Cash flow per share (Unadj.) Rs-5.5354.9-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.913,890.1-  
Shares outstanding (eoy) m267.87332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 7.6%   
Avg P/E ratio x-0.5-10.6 4.4%  
P/CF ratio (eoy) x-1.332.3 -3.9%  
Price / Book Value ratio x0.10.8 15.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8623,814,612 0.0%   
No. of employees `0001.416.9 8.0%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.366,277.4 8.0%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.0-21,348.0 13.9%   
INCOME DATA
Net Sales Rs m7,1811,120,088 0.6%  
Other income Rs m4321,420 0.2%   
Total revenues Rs m7,2231,141,507 0.6%   
Gross profit Rs m94729,352 3.2%  
Depreciation Rs m2,543478,813 0.5%   
Interest Rs m4,37764,635 6.8%   
Profit before tax Rs m-5,931-492,677 1.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0125,652 0.0%   
Tax Rs m-1,924-6,244 30.8%   
Profit after tax Rs m-4,007-360,781 1.1%  
Gross profit margin %13.22.6 503.2%  
Effective tax rate %32.41.3 2,560.3%   
Net profit margin %-55.8-32.2 173.2%  
BALANCE SHEET DATA
Current assets Rs m14,335459,401 3.1%   
Current liabilities Rs m49,809406,402 12.3%   
Net working cap to sales %-494.04.7 -10,440.6%  
Current ratio x0.31.1 25.5%  
Inventory Days Days40320 2,059.7%  
Debtors Days Days17166 257.3%  
Net fixed assets Rs m55,432126,788 43.7%   
Share capital Rs m2680-   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,7014,619,838 0.3%   
Long term debt Rs m9,4781,626,813 0.6%   
Total assets Rs m73,9887,221,859 1.0%  
Interest coverage x-0.4-6.6 5.4%   
Debt to equity ratio x0.60.4 183.1%  
Sales to assets ratio x0.10.2 62.6%   
Return on assets %0.5-4.1 -12.2%  
Return on equity %-27.3-7.8 349.0%  
Return on capital %-6.4-4.8 132.7%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,719400,165 0.4%  
From Investments Rs m-3,148219,839 -1.4%  
From Financial Activity Rs m1,426-686,803 -0.2%  
Net Cashflow Rs m-3-66,466 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 70.95 Rs / USD

Compare STERLING BIOTECH With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: PANACEA BIOTECH  J.B.CHEMICALS  ELDER PHARMA  PIRAMAL ENTERPRISES  SHASUN PHARMA  



Today's Market

Sensex Ends 95 Points Higher; Automobile and IT Stocks Witness Buying(Closing)

Indian share markets traded rangebound throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the automobile sector.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS